Unitary Healthcare has been acquired by Axel Health
Axel Health Oy, headquartered in Finland, has acquired the Finnish software company Unitary Healthcare Oy.
Unitary Healthcare provides a patient logistics solution for public healthcare providers. Their solution manages the logistics for non-urgent patient transfers at the district level, including internal hospital transfers, health center transfers and sharing facilities between municipalities. It also integrates the transfer of things such as patient information.
Founded in 2008, Axel Health is the market leading patient flow management solution in the Nordics, with customers ranging from the largest university hospitals to smaller healthcare providers. The software solution offers patient self-check-in and guidance through the hospital visit, reducing patient queues and freeing up hospital resources as well as hospital operational planning. Its software is provided on a subscription basis. Axel Health is a portfolio company of Standout Capital.
In Finland, Axel Health is the market leader in its sector and continues to grow rapidly. The company’s goal is to be the leading healthcare management software provider in the Nordics, with the best end-to-end solutions to help healthcare organizations optimize their services, whether physical or virtual.
Oaklins’ team in Finland acted as the sell-side financial advisor in this transaction.
Sprechen Sie mit dem Deal Team
Transaktionen
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Mehr erfahrenDie Lindenhofgruppe veräussert ihre Mehrheitsbeteiligung an der LabPoint an Affidea Switzerland
Die LabPoint Medizinische Laboratorien AG wurde von Affidea Switzerland AG übernommen. Mit Affidea hat die Lindenhofgruppe AG einen starken strategischen Partner für die Weiterentwicklung der LabPoint gewonnen. Die Lindenhofgruppe bleibt bedeutende Aktionärin und Grosskundin des Unternehmens. Damit schafft sie die Grundlage für eine nachhaltige Weiterentwicklung von LabPoint unter einer neuen Ankeraktionärin. LabPoint soll ihre Position in der Labordiagnostik weiter stärken und gezielt ausbauen.
Mehr erfahrenArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Mehr erfahren